Your browser doesn't support javascript.
loading
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes.
Groh, Matthieu; Rohmer, Julien; Etienne, Nicolas; Abou Chahla, Wadih; Baudet, Antoine; Chan Hew Wai, Aurélie; Chenivesse, Cécile; Clisson Rusek, Irena; Cottin, Vincent; Decamp, Matthieu; De Groote, Pascal; Delahousse, Fanny; Duployez, Nicolas; Faguer, Stanislas; Gottrand, Frédéric; Huang, Florent; Leblanc, Thierry; Magnan, Antoine; Martin, Thierry; Mortuaire, Geoffrey; Néel, Antoine; Paris, Luc; Petit, Arnaud; Rossignol, Julien; Schleinitz, Nicolas; Soret-Dulphy, Juliette; Staumont-Salle, Delphine; Terrier, Benjamin; Terriou, Louis; Viallard, Jean-François; Lefèvre, Guillaume; Kahn, Jean-Emmanuel.
Affiliation
  • Groh M; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France. m.groh@hopital-foch.com.
  • Rohmer J; Department of Internal Medicine, Hôpital Foch, Suresnes, France. m.groh@hopital-foch.com.
  • Etienne N; Inserm, U1286 - INFINITE - Institute for Translational Research in Inflammation, University of Lille, CHU Lille, Lille, France. m.groh@hopital-foch.com.
  • Abou Chahla W; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France. m.groh@hopital-foch.com.
  • Baudet A; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
  • Chan Hew Wai A; Department of Internal Medicine, University of Sorbonne-Paris-Cité, APHP, CHU Bichat, Paris, France.
  • Chenivesse C; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
  • Clisson Rusek I; Department of Infectious Diseases and Tropical Medicine, University of Sorbonne-Paris-Cité, APHP, CHU Necker-Enfants Malades, Paris, France.
  • Cottin V; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
  • Decamp M; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
  • De Groote P; Department of Pediatric Hematology, University of Lille, CHU Lille, Lille, France.
  • Delahousse F; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
  • Duployez N; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
  • Faguer S; Department of Internal Medicine, CH Annecy Genevois, Metz Tessy, France.
  • Gottrand F; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
  • Huang F; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
  • Leblanc T; Department of Pharmacology, Hôpital Foch, Suresnes, France.
  • Magnan A; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
  • Martin T; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
  • Mortuaire G; CNRS, Inserm, Institut Pasteur de Lille, U1019-UMR9017-CIIL-Centre d'Infection et d'Immunité de Lille, University of Lille, CHU Lille, Lille, France.
  • Néel A; CRISALIS (Clinical Research Initiative in Severe Asthma: a Lever for Innovation and Science), F-CRIN Network, INSERM US015, Toulouse, France.
  • Paris L; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
  • Petit A; Association Pour l'Information sur les Maladies à Eosinophiles, Bourg-la-Reine, France.
  • Rossignol J; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
  • Schleinitz N; Department of Respiratory Medicine, Hôpital Louis Pradel, UMR754 INRAE, University of Lyon 1, Hospices Civils de Lyon, Lyon, France.
  • Soret-Dulphy J; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
  • Staumont-Salle D; Department of Cytogenetics, CHU de Caen, Caen, France.
  • Terrier B; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
  • Terriou L; Department of Internal Medicine, National Reference Center for Hypereosinophilic Syndromes (CEREO), Hôpital Foch, 40, Rue Worth, 92151, Suresnes, France.
  • Viallard JF; Department of Cardiology, University of Lille, CHU Lille, Lille, France.
  • Lefèvre G; Department of Internal Medicine, University of Paris Saclay, APHP, CHU Ambroise Paré, Boulogne-Billancourt, France.
  • Kahn JE; , Nantes, France.
Orphanet J Rare Dis ; 18(1): 100, 2023 04 30.
Article in En | MEDLINE | ID: mdl-37122022
ABSTRACT
Eosinophilic-related clinical manifestations are protean and the underlying conditions underpinning eosinophilia are highly diverse. The etiological workup of unexplained eosinophilia/hypereosinophilia can be challenging, and can lead sometimes to extensive, inappropriate, costly and/or invasive investigations. To date, guidelines for the etiological workup and management of eosinophilia are mainly issued by hematologists, and thus mostly cover the scope of clonal hypereosinophilic syndromes (HES). Here, thanks to an extensive literature review, and thanks to the joint work of a large panel of experts involving physicians from both adult and pediatric medicine and from various subspecialties (as well as a representative of a patients' association representative), we provide recommendations for both the step-by step diagnostic workup of eosinophilia (whether unexplained or within specific contexts) as well as the management and follow-up of the full spectrum of eosinophilic disorders (including clonal, reactive, lymphocytic and idiopathic HES, as well as single-organ diseases). Didactic prescription summaries intended to facilitate the prescription of eosinophil-targeted drugs are also provided, as are practical diagnostic and therapeutic algorithms. Lastly, this set of recommendations also includes a summary intended for general practitioners, as well as an overview of the therapeutic patient education program set up by the French reference center for HES. Further updates will be mandatory as new validated information emerges.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypereosinophilic Syndrome Type of study: Etiology_studies / Guideline Limits: Adult / Child / Humans Language: En Journal: Orphanet J Rare Dis Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: Francia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hypereosinophilic Syndrome Type of study: Etiology_studies / Guideline Limits: Adult / Child / Humans Language: En Journal: Orphanet J Rare Dis Journal subject: MEDICINA Year: 2023 Document type: Article Affiliation country: Francia